COMPARISON OF THE EFFECT OF SILDENAFIL AND TADALAFIL ON PULMONARY HYPERTENSION ASSOCIATED WITH HEMODYNAMICALLY SIGNIFICANT PDAS TREATMENT OF PULMONARY HYPERTENSION IN HS-PDA PATIENTS. Journal of Pharmaceutical Negative Results, [S. l.], p. 3266–3274, 2022. DOI: 10.47750/pnr.2022.13.S08.401. Disponível em: https://mail.pnrjournal.com/index.php/home/article/view/4563.. Acesso em: 13 jun. 2026.